To assess the effect of kinase, inhibitors cells were incubated in the absence or presence of the p38-mitogen-activated protein kinase (MAPK) inhibitor SB203580 (Calbiochem, Darmstadt, Germany) and the c-Jun N-terminal kinase (JNK) inhibitor SP600125 (Calbiochem) for 24h (Liuet al, 2007a). == Single cell movement == Cells L-779450 (50000 per well) were seeded onto fibronetin-coated (5gml1in PBS) six-well plates and grown for 20h. Endogenous SPARC expression can be modulated by FGFR1-III isoform expression. In addition, PDAC cells may inhibit endogenous SPARC expression in surrounding PSCs by paracrine actions. Keywords:osteonectin, SPARC, fibroblast growth factor receptor, pancreatic cancer, pancreatic stellate cells Secreted protein acidic and rich in cysteine (SPARC) or osteonectin is L-779450 a 3233 kDa calcium-binding glycoprotein shown to associate with the cell membrane and membrane receptors (Yan and Sage, 1999). It belongs to a family of matricelluar proteins and is divided into three modules that exert various functions (Bradshaw and Sage, 2001). It functions not only to modulate cellcell and cellmatrix L-779450 interactions, but also has de-adhesive and growth inhibitory properties in non-transformed cells (Tai and Tang, 2008). In cancer, SPARC may exert divergent actions reflecting the complexity of this protein (Clark and Sage, 2008;Podhajceret al, 2008). Thus, in certain types of cancers, such as melanomas and gliomas, SPARC is associated with a highly aggressive tumour phenotype, whereas in others, mainly ovarian, neuroblastomas, and colorectal cancers, SPARC may function as a tumour suppressor (Tai and Tang, 2008). These functions are thought to be exerted in part by its ability to counteract effects of several growth factor families including fibroblast growth factors (FGFs) (Yan and Sage, 1999;Franckiet al, 2003;Motamedet al, 2003). Modulation of FGF actions by SPARC is mediated by FGF receptor (FGFR) 1, because FGFR1 was reported to be indispensable for SPARC-induced inhibition of FGF signalling (Motamedet al, 2003). The presence L-779450 of several FGFR1 isoforms generated by alternative mRNA splicing makes the analysis of FGFR1 and SPARC interactions difficult. FGF actions strongly depend on the presence of specific FGFR isoforms and can be modulated by changes in isoform expression (Ornitzet al, 1996;Kornmannet al, 2001;Liuet al, 2007a). Alternative splicing of the second half of Ig-like domain III generates particular important isoforms, because this region determines ligand-binding specificity (Ornitzet al, 1996;Plotnikovet al, 2000). As a consequence, over-expression of FGFR1-IIIc in pancreatic cancer promoted tumourigenesis, whereas over-expression of FGFR1-IIIb inhibited the malignant phenotype (Kornmannet al, 2002;Liuet al, 2007b). In addition, several FGFs, signalling through FGFR1-IIIc, are highly over-expressed in human pancreatic ductal adenocarcinoma (PDAC) (Yamanakaet al, 1993). Several recent studies reported increased SPARC levels in human PDAC (Satoet al, 2003;Guweidhiet al, 2005) associated with poor prognosis (Infanteet al, 2007). SPARC expression was absent in most of the cancer cells, but instead present at high levels in the peritumoural tissue harbouring fibroblasts and pancreatic stellate cells (PSCs) (Guweidhiet al, 2005;Infanteet al, 2007). Despite these recent efforts, the functions of SPARC and its associations with FGFR1-III isoforms in PDAC remain unclear. Therefore, the aim of this study was to elucidate SPARC functions and endogenous SPARC regulation depending on FGFR1-III isoforms expression in PDAC cells and its interaction with PSC cells. == Materials and methods == == Cell Mouse monoclonal to SNAI2 culture == ASPC-1, BXPC-3, CAPAN-1, MIA PaCa-2, and PANC-1 human pancreatic cancer cells were purchased from American Type Culture Collection (ATCC, Manassas, VA, USA), COLO357 and T3M4 human pancreatic cancer cells were a gift from M Korc (Dartmouth Medical School, Hanover, NH, USA). Human PSC were isolated and characterised as described earlier (Bachemet al,.